Investigator Grant Payments
INVESTIGATOR GRANT PAYMENTS ARTICLES
-
![confident successful team-GettyImages-1330547182]( "How To Choose Fit-For-Purpose Tech With The Modified Delphi Method")
How To Choose Fit-For-Purpose Tech With The Modified Delphi MethodWhen it comes to selecting a new clinical trial technology, consultant Aurea Flores, Ph.D. suggests stakeholders and end users explore options and make recommendations based on a modified version of the Delphi Method.
INVESTIGATOR GRANT PAYMENTS WHITE PAPERS AND CASE STUDIES
-
![GeyyImages-1133420240 payments]( "Navigating The Complexities Of Clinical Trial Site Payments Forecasting")
Navigating The Complexities Of Clinical Trial Site Payments ForecastingAdvanced technology and best practices have the potential to revolutionize clinical trial site payment forecasting, leading to significant improvements in overall trial efficiency and management.
-
![GettyImages-953164092 laser]( "University Of Ottawa Relies On The BEAMAGE Series To Measure Laser Profiles")
University Of Ottawa Relies On The BEAMAGE Series To Measure Laser ProfilesThe University of Ottawa lab successfully used beam profilers to improve Power-Over-Fiber receiver chip development, ensuring precise, efficient laser measurements for advanced photonic research.
-
![Trimble - Miami WASD]( "Maximizing e-Builder To Reduce Review Times")
Maximizing e-Builder To Reduce Review TimesDiscover how the Miami-Dade Water & Sewer Department (WASD) streamlined their project evaluation with e-Builder, saving time and enhancing project documentation reliability.
INVESTIGATOR GRANT PAYMENTS PRODUCTS & SERVICES
Review how a comprehensive cGMP manufacturing facility is poised to support the development and manufacture of your mammalian cell program.
Exosomes are nano-sized vesicles that enable unique intercellular communication by transferring DNAs, microRNAs, non-coding RNAs, and lipids.
The C10-1000WG is a WR10 10dB waveguide coupler featuring high directivity over a 75-100GHz operational bandwidth built with high precision and then gold plated for high corrosion resistance.
PHCbi brand's 25.7 cu.ft (729L) ultra-low temperature freezer operates on 220V and features VIP Plus vacuum insulated panels to deliver reliable temperature uniformity throughout the chamber. It is ENERGY STAR® Certified and uses only 7.96Wh per day.
On-site labs with our own personnel offer greater control of samples and timelines, minimizing risk for our customers.
The MM1-0626SCSP2 is a highly linear passive GaAs double balanced MMIC mixer suitable for both up and down-conversion applications.
PHCbi brand’s 8.1 cu.ft (230 L) Cell-IQ series CO₂ incubator features a patented Direct Heat and Air Jacket system, dual IR sensor, SafeCell™ UV, and inCu-saFe® interior to helps ensure precise temperature, CO₂ levels, and contamination control. A high-speed H₂O₂ vapor decontamination cycle completes in under three hours, supporting rapid turnaround in high-throughput labs. This stackable, medium-capacity unit is ideal for scaling up cell culture workflows and integrating with lab automation systems.
INVESTIGATOR GRANT PAYMENTS NEWS
-
BriteCore To Host Webinar On Reducing Insurance Payment Processing Costs By Two-Thirds Through PAS And Payments Integration8/27/2025
BriteCore, a leading provider of cloud-native core insurance platforms for P&C insurers, announced today it is hosting a webinar at 2:00 p.m. EST on September 18, 2025 to share insights, best practices, and new approaches for reducing payment processing expenses for insurers.
-
What To Do With Dirty PFAS Filters? UB Researchers Think Plasma Treatment Can Make Them Reusable6/2/2025
It’s known as granular activated carbon, or GAC. Whether deployed in a water treatment plant or the pitcher in your fridge, this highly adsorbent organic material can easily capture water pollutants.
-
Yokogawa Co-Awarded DARPA Project To Advance Oceanic Energy Harvesting1/8/2025
Yokogawa Corporation of America, a provider of advanced solutions in the areas of measurement, control, and information, is pleased to announce that a collaborative team including Yokogawa has been awarded a research project by the Defense Advanced Research Projects Agency (DARPA) to develop and test a biologically fueled energy source to power research and sensing devices throughout the world’s oceans.
-
Zelis Accelerates Expansion Into P&C Market With Duck Creek Partnership To Modernize Claims Payments11/10/2025
Zelis, a leading provider of healthcare technology solutions, today announced its expansion into the property and casualty (P&C) insurance market through a strategic partnership with Duck Creek Technologies, the global intelligent solutions provider defining the future of property and casualty (P&C) and general insurance.
-
Transcenta Therapeutics Announces Strategic Collaboration And Non-Exclusive Licensing Agreement To Advance Integrated Continuous Biomanufacturing And Expand Global Access To Affordable Biologics12/28/2025
Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, today announced it has entered into a strategic collaboration and non-exclusive licensing agreement with EirGenix Inc. (“EirGenix”) (TWSE: 6589), a global biopharmaceutical development and manufacturing company.
ABOUT
Investigator Grant Payments
In the clinical trials industry, there is usually the pressure of making profits while maintaining regulatory compliance. In order to maximize on their research and development spending, pharmaceutical companies are reducing clinical trial cycle times.
However, there are an increasing number of clinical trials, with more complex protocols and more stringent regulatory requirements. Despite all these, many sponsors issue late payments to investigative sites, and many of these sites are struggling to maintain financial viability.
If the sponsors want to maintain strong, effective investigative sites, they need to build strong relationships with them. This involves coming up with a more effective approach to investigator grant payments. This will not only improve investigator relationships and satisfaction, it will help sponsors to accelerate cycle times and reduce the costs of clinical trials.
First, there is a need to understand that accounts payable in the clinical trials industry are very complex. Investigator grant payments are driven by the terms of the clinical trial agreement. These agreements are highly complex documents with various variables that can impact on the grant payment.
There is also a need for better management of investigator grant payments through the right personnel. Apart from having a background in finance and accounting, those in charge ought to have some experience in financial management of clinical trials.
Such a person would understand the standard process for a clinical trial, from screening to treatment of patients. He or she should be able to read and understand how the clinical study is progressing against the clinical trial agreement.